Cargando…
PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
PF-05231023, a long-acting FGF21 analogue, is a promising potential pharmacotherapy for the treatment of obesity and associated comorbidities. Previous studies have shown the potential of FGF21 and FGF21-like compounds to decrease body weight in mice, non-human primates, and humans; the precise mech...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954843/ https://www.ncbi.nlm.nih.gov/pubmed/27405817 http://dx.doi.org/10.1007/s10928-016-9481-1 |